We are live on
!
Find out more
AL
Aspiriant LLC Portfolio holdings
AUM
$3.51B
1-Year Est. Return
13.98%
This Fund
S&P 500
This Quarter
Est. Return
+5.05%
1 Year Est. Return
+13.98%
3 Year Est. Return
+39.43%
5 Year Est. Return
+43.32%
10 Year Est. Return
+133.07%
AUM
$1.17B
AUM Growth
+$69.9M
(+6.3%)
Cap. Flow
-$123M
Cap. Flow
% of AUM
-10.45%
Top 10 Holdings %
Top 10 Hldgs %
45.17%
Holding
233
New
50
Increased
46
Reduced
102
Closed
21
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$30.7M |
| 2 |
Vanguard Dividend Appreciation ETF
VIG
|
+$27.7M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$19.3M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$19.1M |
| 5 |
Vanguard Total Bond Market
BND
|
+$13.3M |
Top Sells
Sector Composition
| 1 | Financials | 4.56% |
| 2 | Technology | 3.54% |
| 3 | Communication Services | 2.54% |
| 4 | Healthcare | 2.13% |
| 5 | Industrials | 1.35% |
Similar funds
BCP
ACA
IIM
TH
TYCC
TCM
DILIC
KCM
Aspiriant LLC's Q1 2017 Portfolio in Review
As of Q1 2017, Aspiriant LLC held 233 positions worth $1.17B, up 6.3% from $1.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Aspiriant LLC withdrew a net $123M in Q1 2017, closing 21 positions and reducing 102 holdings. Its most notable exit was VanEck Biotech ETF, an estimated $2.5M position sold in full.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, down from 5.1% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Aspiriant LLC opened a new position in Vanguard Short-Term Corporate Bond ETF worth $19.1M.
- Aspiriant LLC's largest Q1 2017 buy was Vanguard Short-Term Corporate Bond ETF: 240,133 shares worth $19.1M.
- Aspiriant LLC added most to Vanguard S&P 500 ETF in Q1 2017, an estimated $30.7M increase.
- Aspiriant LLC's biggest Q1 2017 reduction was Berkshire Hathaway Class A, cutting an estimated $124M.
- Aspiriant LLC fully exited VanEck Biotech ETF in Q1 2017, selling an estimated $2.5M.
- Aspiriant LLC's ten largest holdings make up 45% of its $1.17B portfolio in Q1 2017.
- Aspiriant LLC opened 50 new positions and closed 21 in Q1 2017.
- Aspiriant LLC's portfolio value rose 6.3% quarter-over-quarter to $1.17B.
Based on Aspiriant LLC's 13F filing for Q1 2017, filed 15 May 2017.